Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry

INTRODUCTION: Cannabis-based medicinal products (CBMPs) have been identified as a promising novel therapeutic for symptoms and comorbidities related to autism spectrum disorder (ASD). However, there is a paucity of clinical evidence of their efficacy and safety. Objective: This case series aims to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Erridge, Simon, Kerr-Gaffney, Jess, Holvey, Carl, Coomber, Ross, Barros, Daniela A. Riano, Bhoskar, Urmila, Mwimba, Gracia, Praveen, Kavita, Symeon, Chris, Sachdeva-Mohan, Simmi, Sodergren, Mikael H., Rucker, James J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500308/
https://www.ncbi.nlm.nih.gov/pubmed/36159065
http://dx.doi.org/10.1177/20451253221116240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500308/
https://www.ncbi.nlm.nih.gov/pubmed/36159065
http://dx.doi.org/10.1177/20451253221116240

Ejemplares similares